Advances in the early diagnosis of hepatocellular carcinoma

Cited by (495)

Items 101–200 of 495

1. The combined characteristics of cholesterol metabolism and the immune microenvironment may serve as valuable biomarkers for both the prognosis and treatment of hepatocellular carcinoma
   Weiyu Bai · 2023 · Heliyon
2. Low SAA4 gene expression is associated with advanced HCC stage and a poor prognosis
   Shilong Li, Dejun Kong, Weiqi Zhang, Yan Li, Hao Wang, Ruining Yang, Qian Sun, Zhenglu Wang, Zhongwei Zhang · 2024 · Clinical and Experimental Medicine
3. Competitive electrochemical aptasensor for high sensitivity detection of liver cancer marker GP73 based on rGO-Fc-PANi nanocomposites
   Guiyin Li, Bo Wang, Shengnan Li, Xinhao Li, Ruijie Yan, Xiaohong Tan, Jintao Liang, Zhide Zhou · 2024 · Bioelectrochemistry
4. Single cell glycan-linkages profiling for hepatocellular carcinoma early diagnosis using lanthanide encoded bacteriophage MS2 based ICP-MS
   Yong Liang, Zhen Liu, Dongliang Zuo, Jianbin Chen, Jianbin Chen, Xiaowen Yan, Pingguo Liu, Qiuquan Wang · 2024 · Talanta
5. RETRACTED: Structure of POU2AF1 recombinant protein and it affects the progression and treatment of liver cancer based on WGCNA and molecular docking analysis
   Xin Li, Hongxu Zhou, Ruiyang Ma, Wei Guo, Xu Yang, Xiang Li, Zhe Liu, Yifan Zhong, Zuoqian Jing · 2024 · International Journal of Biological Macromolecules · Retracted
6. Porous Silicon Particle-Assisted Mass Spectrometry Technology Unlocks Serum Metabolic Fingerprints in the Progression From Chronic Hepatitis B to Hepatocellular Carcinoma
   Xinrong Jiang, Liye Tao, Shuo Cao, Zhengao Xu, Shuang Zheng, Huafang Zhang, Xinran Xu, Xuetong Qu, Xingyue Liu, Jiekai Yu et al. · 2025 · ACS Applied Materials & Interfaces
7. A split-type near-infrared photoelectrochemical and colorimetric dual-mode biosensor for the high-performance determination of HepG2 cells
   Yawen Hong, Lian Xu, Hengwei Sun, Wen Wu, Xiaojun Cai, Qingfeng Lin, Xiaoyang Chen, Yanying Wang, Chunya Li, Jinmiao Qu et al. · 2025 · Talanta
8. Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA–mRNA network and signature analysis
   Fei Wang, Xichun Kang, Yaoqi Li, Jianhua Lu, Xiling Liu, Huimin Yan · 2024 · Scientific Reports
9. Comparison of the prognosis of BCLC stage A ruptured hepatocellular carcinoma patients after undergoing transarterial chemoembolization (TACE) or hepatectomy: a propensity score-matched landmark analysis
   Feng Xia, Qiao Zhang, Xiaoping Chen, Bixiang Zhang, Elijah Ndhlovu, Mingyu Zhang, Peng Zhu · 2022 · Surgical Endoscopy
10. ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle
    Jing Zhen, Yun Ke, Jingying Pan, Minqin Zhou, Hong Zeng, Gelin Song, Zichuan Yu, Bidong Fu, Yue Liu, Da Huang et al. · 2022 · Aging
11. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis
    Jia Jie Li, Yanqing Lv, Huifan Ji · 2022 · PeerJ
12. Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology
    Caiyun Zhang, Hongjiao Xiang, Junmin Wang, Gaoxuan Shao, Peilun Ding, Ying Gao, Hanchen Xu, Guang Ji, Tao Wu · 2023 · Journal of Ethnopharmacology
13. LncRNA SH3BP5-AS1 promotes hepatocellular carcinoma progression by sponging miR-6838-5p and activation of PTPN4
    Xinyang Zhao, Xinfeng Zhu, Chaowen Xiao, Zouxiao Hu · 2024 · Aging
14. Advances in gross tumor target volume determination in radiotherapy for patients with hepatocellular carcinoma
    Kangning Meng, Guanzhong Gong, Rui Liu, Shanshan Du, Yong Yin · 2024 · Frontiers in Oncology
15. Unveiling the functions of five recently characterized lncRNAs in cancer progression
    Zhicheng Li, Dan Wang, Xiaojun Zhu · 2024 · Clinical & Translational Oncology
16. Identification of novel M2 macrophage‐related molecule ATP6V1E1 and its biological role in hepatocellular carcinoma based on machine learning algorithms
    Sen Zhao, Meimei Liu, Hua Zhou · 2024 · Journal of Cellular and Molecular Medicine
17. Screening of Cancer-Specific Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma Based on a Proteome Microarray
    Wudi Hao, Danyang Zhao, Yuan Meng, Mei Yang, Meichen Ma, Jingwen Hu, Jianhua Liu, Xiaosong Qin · 2024 · Molecular & Cellular Proteomics
18. Bridging the Gap Between Imaging and Molecular Characterization: Current Understanding of Radiomics and Radiogenomics in Hepatocellular Carcinoma
    Liying Ren, Dong Bo Chen, Xuanzhi Yan, Shaoping She, Yao Yang, Xue Zhang, Weijia Liao, Hongsong Chen · 2024 · Journal of Hepatocellular Carcinoma
19. Alpha-fetoprotein, glypican-3, and kininogen-1 as biomarkers for the diagnosis of hepatocellular carcinoma
    Diana Gabriela Domínguez-Lazcano · 2024 · International Journal of Clinical and Experimental Pathology
20. Metabolism profiles of tannins in Phyllanthus emblica L. and its immunotherapeutic potential against hepatocellular carcinoma by re-educating tumor microenvironment
    Zihao Chang, Zhaohui Wang, Yinxin Chen, Yuqi Liu, Ye Gao, Yitong Cui, Le Wang, Yue Liu, Ruiyang Cheng, Runping Liu et al. · 2025 · Phytomedicine
21. Prognostic impact of extracellular volume fraction derived from equilibrium contrast-enhanced CT in HCC patients receiving immune checkpoint inhibitors
    Xiaona Fu, Yusheng Guo, Kailu Zhang, Zhixuan Cheng, Chanyuan Liu, Yi Ren, Lianwei Miao, Weiwei Liu, Shanshan Jiang, Chen Zhou et al. · 2025 · Scientific Reports
22. Construction of a prognostic model for hepatocellular carcinoma based on necrosis by sodium overload-related genes and identification of ANKRD13B as a new prognostic marker
    Xiangyu Qu, Yigang Zhang, Yilun Shi, Suchen Wang, Yi Jer Tan, Lianbao Kong, Deming Zhu · 2025 · Functional & Integrative Genomics
23. Advancement in hepatocellular carcinoma research: Biomarkers, therapeutics approaches and impact of artificial intelligence
    Devraj Rajak, Priyanshu Nema, Arvindra Sahu, Satyamshyam Vishwakarma, Sushil K. Kashaw · 2025 · Computers in Biology and Medicine
24. On the Electrochemical Detection of Alpha-Fetoprotein Using Aptamers: DNA Isothermal Amplification Strategies to Improve the Performance of Weak Aptamers
    Ramón Lorenzo-Gómez, Daniel González-Robles, Rebeca Miranda‐Castro, Noemı́ de-los-Santos-Álvarez, Marı́a Jesús Lobo-Castañón · 2020 · Biosensors
25. Trends of liver cell carcinoma mortality in the United States by demographics and geography
    Sishir Doddi, Oscar Salichs, Taryn Hibshman, Puneet Bhargava · 2023 · Current Problems in Diagnostic Radiology
26. Heat shock protein HSPA13 promotes hepatocellular carcinoma progression by stabilizing TANK
    Xuesong Cen, Yuyan Lu, Jing Lü, Changhong Luo, Ping Zhan, Yizhe Cheng, Fan Yang, Chengrong Xie, Zhenyu Yin, Fuqiang Wang · 2023 · Cell Death Discovery
27. Unveiling the Impact of Hemodynamics on Endothelial Inflammation‐Mediated Hepatocellular Carcinoma Metastasis Using a Biomimetic Vascular Flow Model
    Jia He, Peiyan Duan, Yi Liu, Tang Feng, Shuo Wang, Xinyi Lin, Jing Xie, Xiaoheng Liu · 2024 · Advanced Healthcare Materials
28. The regulation of hypoxia-related lncRNAs in hepatocellular carcinoma
    Xue-Jing Wang, Xiao-Jun Wang · 2024 · Discover Oncology
29. Reserpine, a novel N6-methyladenosine regulator, reverses Lenvatinib resistance in hepatocellular carcinoma
    Lei Zhao, Heyao Ma, Yuhui Jiang, Yingying Li, Ning Guo, Yu Chen, Xiaowen Jiang, Yunpeng Zhao, Jingjing Yang, Yifei Liu et al. · 2024 · Phytomedicine
30. Prediction of Multiple Serum Tumor Markers in Hepatolithiasis Complicated with Intrahepatic Cholangiocarcinoma
    Hua Zhao, Benliang Lu · 2022 · Cancer Management and Research
31. Downregulated lncRNA SNHG18 Suppresses the Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma and Meditates the Antitumor Effect of Oleanolic Acid
    Wenqi Song, Xuemei Zhang, Lin Feng, Yongwei Lai, Tongtong Li, Pengxia Zhang · 2022 · Cancer Management and Research
32. MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular carcinoma
    Somaia Shehab-Eldeen, Mohamed F. Metwaly, Safa M. Saber, Salah Mohamed El-Kousy, Eman A.E. Badr, Abdallah Said Essa · 2022 · Digestive and Liver Disease
33. Overexpression of TCERG1 as a prognostic marker in hepatocellular carcinoma: A TCGA data-based analysis
    Pan Yang, Huaifeng Liu, Yan Li, Qunwei Gao, Xin Chen, Junyan Chang, Yangyang Li, Shuran Chen, Rui Dong, Huazhang Wu et al. · 2022 · Frontiers in Genetics
34. Cancer chemopreventive potential of cooked glutinous purple rice on the early stages of hepatocarcinogenesis in rats
    Huina Guo, Charatda Punvittayagul, Arpamas Vachiraarunwong, Warunyoo Phannasorn, Rawiwan Wongpoomchai · 2022 · Frontiers in Nutrition
35. Hepatocellular Carcinoma Surveillance
    Eden Koo, Amit G. Singal · 2023 · Surgical Oncology Clinics of North America
36. Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications
    Chenxi Xie, Xiaopei Hao, Hao Yuan, Chongyu Wang, Razinah Sharif, Haibo Yu · 2024 · OncoTargets and Therapy
37. Development of prognostic models for advanced multiple hepatocellular carcinoma based on Cox regression, deep learning and machine learning algorithms
    Jie Shen, Yu Zhou, Junpeng Pei, Dashuai Yang, Kailiang Zhao, Youming Ding · 2024 · Frontiers in Medicine
38. Ribosomal proteins in hepatocellular carcinoma: mysterious but promising
    Qian Su, Huizhen Sun, Ling Mei, Ying Yan, Huimin Ji, Le Chang, Lunan Wang · 2024 · Cell & Bioscience
39. Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospective multi-center cohort study
    Feng Zhang, Yong‐Shuai Wang, Shao-Peng Li, B. R. Zhao, Nan Huang, Ruipeng Song, Fanzheng Meng, Zhi-Wen Feng, Shen‐Yu Zhang, Hua‐Chuan Song et al. · 2024 · Journal of Gastroenterology
40. miRNAs-Set of Plasmatic Extracellular Vesicles as Novel Biomarkers for Hepatocellular Carcinoma Diagnosis Across Tumor Stage and Etiologies
    Francisco A. Molina-Pelayo, David Zárate-López, Rosendo García-Carrillo, César Rodríguez-Beas, Ramón Alfonso Iñiguez-Palomares, José L. Rodríguez-Mejía, Adriana Soto-Guzmán, Gabriela Velasco-Loyden, Mónica Sierra-Martínez, Adolfo Virgen‐Ortiz et al. · 2025 · International Journal of Molecular Sciences
41. Bioactive natural alkaloid 6−Methoxydihydrosanguinarine exerts anti−tumor effects in hepatocellular carcinoma cells via ferroptosis
    Linfen Han, Chengchang Gao, Xiaorui Jin, Yingping Li, Liangjie Chen, Donglin Li, Qinqin Deng, Xueli Bian · 2025 · Frontiers in Pharmacology
42. Exploring the Mechanisms of Arsenic Trioxide (Pishuang) in Hepatocellular Carcinoma Based on Network Pharmacology
    Xinmiao Wang, Luchang Cao, Jingyuan Wu, Guanghui Zhu, Xiaoyu Zhu, Xiaoxiao Zhang, Duoduo Han, Ning Shui, Baoyi Ni, Jie Li · 2021 · Evidence-based Complementary and Alternative Medicine
43. FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma
    Jing Zhen, Jingying Pan, Xuanrui Zhou, Zi-Chuan Yu, Yi-Ke Jiang, Yiyang Gong, Yongqi Ding, Yue Liu, Liang-Yun Guo · 2023 · Aging
44. In Silico Analysis of MicroRNA Expression Data in Liver Cancer
    Nourhan Abu-Shahba, Elsayed Hegazy, Faiz M. Khan, Mahmoud ElHefnawi · 2023 · Cancer Informatics
45. ST8SIA6-AS1, a novel lncRNA star in liver cancer
    Cheng Qiu, Haoran Fan, Siyu Tao, Ziqing Deng, Hongliang Luo, Fangteng Liu · 2024 · Frontiers in Cell and Developmental Biology
46. Intratumoral microbiota: an emerging force in diagnosing and treating hepatocellular carcinoma
    Huanxiang Liu, Jiahao Zhang, Yuye Rao, Shengjie Jin, Chi Zhang, Dousheng Bai · 2024 · Medical Oncology
47. Mechanisms of Targeted Drug Delivery for Liver Cancer: Active, Passive, and Subcellular Strategies
    Tian Yang, Yu-Sheng Shi · 2025 · Journal of Biosciences and Medicines
48. Role of hepatotropic viruses in promoting hepatocellular carcinoma—current knowledge and recent advances
    Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, Dominik Malicki, Aleksandra Piąta, Dominika Lorek, Jakub Janczura · 2025 · Medical Oncology
49. MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center
    Gabriela Hernandez‐Meza, Naïk Vietti Violi, Daniela Said, Eitan Novogrodsky, Dillan F. Villavisanis, Samuel Z. Maron, Justin J. Frere, Thomas D. Schiano, Scott L. Friedman, Paolo Boffetta et al. · 2021 · Abdominal Radiology
50. The diagnostic utility of microRNA 222-3p, microRNA 21-5p, and microRNA 122-5p for HCV-related hepatocellular carcinoma and its relation to direct-acting antiviral therapy
    Ahmed M. Khairy, Marwa K. Ibrahim, Mohamed Abdelrahman, Rabab Fouad, Naglaa Ali Zayed, Yosra Ayman, Zeinab Abdellatef, Ayman Yosry · 2022 · Arab Journal of Gastroenterology
51. Recognition of liver tumors by predicted hyperspectral features based on patient's computed tomography radiomics features
    Xuehu Wang, Tianqi Wang, Yongchang Zheng, Xiaoping Yin · 2023 · Photodiagnosis and Photodynamic Therapy
52. CircGPC3 promotes hepatocellular carcinoma progression and metastasis by sponging miR-578 and regulating RAB7A/PSME3 expression
    Linling Ju, Yunfeng Luo, Xiaohui Cui, Hao Zhang, Lin Chen, Min Yao · 2024 · Scientific Reports
53. Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors
    Yen, Carol, Epling, John W., Rockwell, Michelle, Vaughn-Cooke, Monifa · 2026 · Diagnostics
54. [ 18 F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC)
    Youngho Seo, Miranda C. Craig, Stephanie T. Murphy, Jinjin Feng, Xin Chen, Mariia O. Yuneva · 2022 · Molecular Imaging
55. Extracellular Vesicles, Circadian Rhythms, and Cancer: A Comprehensive Review with Emphasis on Hepatocellular Carcinoma
    Baharan Fekry, Lierni Ugartemendia, Nestor F. Esnaola, Laura M. Goetzl · 2024 · Cancers
56. Rewiring immunometabolism in hepato-biliary-pancreatic cancers: Unraveling TME-mediated metabolic suppression and advancing next-generation immunotherapeutic approaches
    Yimao Wu, Zichang Chen, Yinting Hu, Shuai Ren, Mengyao Li · 2026 · Autoimmunity Reviews
57. Decoding cell-type contributions to the cfRNA transcriptomic landscape of liver cancer
    Aram Safrastyan, Christian Höner zu Siederdissen, Damian Wollny · 2023 · Human Genomics
58. DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma
    Xiaochuan Zhang, Wenyu Wang, Shanshan Mo, Xueying Sun · 2024 · Digestive Diseases and Sciences
59. Genes of DLK1-DIO3 Locus and miR-379/656 Cluster is a Potential Diagnostic and Prognostic Marker in Patients With Hepatocellular Carcinoma: A Systems Biology Study.
    S. Karunakara, R. Mehtani, S. P. Kabekkodu, D. Kumar, P. Santhekadur · 2024 · Journal of Clinical and Experimental Hepatology
60. HTR1D regulates the PI3K/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenib
    Yingai Zhang, Yuting Zhang, Shuai Feng Zhou, Mujeeb Ur Rehman, Fankai Lin, Jianquan Zhang, Hailong Zhou · 2025 · BMC Cancer
61. The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics
    Yan Fang, Hongming Yang, Guiming Hu, Jiakun Lu, Jun Zhou, Na Gao, Yuhan Gu, Cunzhen Zhang, Jinhuan Qiu, Yuanyuan Guo et al. · 2022 · Journal of Translational Medicine
62. RNA binding protein PUM2 promotes hepatocellular carcinoma proliferation and apoptosis via binding to the 3'UTR of BTG3
    Zhenhua Liu, Chunye Lv · 2022 · Oncology Letters
63. Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesis
    Min Yao, Jianjun Wang, Xiyu Chen, Wenli Sai, Jie Yang, Defeng Wang, Li Wang, Dengfu Yao · 2022 · Hepatobiliary & pancreatic diseases international
64. Multi-omics analysis of pyroptosis regulation patterns and characterization of tumor microenvironment in patients with hepatocellular carcinoma
    Bingbing Shang, Ruohan Wang, Haiyan Qiao, Xixi Zhao, Liang Wang, Shaoguang Sui · 2023 · PeerJ
65. Can Modifications of LR‐M Criteria Improve the Diagnostic Performance of Contrast‐Enhanced Ultrasound LI‐RADS for Small Hepatic Lesions up to 3 cm?
    Wei-Che Huang, Rong Wen, Yuquan Wu, Peng Lin, Danxia Guo, Yuye Peng, Dun Liu, Meiyan Mou, Fenghuan Chen, Fen Huang et al. · 2023 · Journal of Ultrasound in Medicine
66. Nucleus‐localized circSLC39A5 suppresses hepatocellular carcinoma development by binding to STAT1 to regulate TDG transcription
    Meiliang Liu, Mingshuang Lai, Deyuan Li, Ruirui Zhang, Lijun Wang, Wenyi Peng, Jialei Yang, Wanting He, Yonghong Sheng, Suyang Xiao et al. · 2023 · Cancer Science
67. Volatile organic compounds for diagnosis of early hepatocellular carcinoma in at-risk patients
    Thanikan Sukaram, Rossarin Tansawat, Chonlada Phathong, Rungsun Rerknimitr, Roongruedee Chaiteerakij · 2024 · Clinica Chimica Acta
68. Risk of cardiovascular death in patients with hepatocellular carcinoma based on the Fine-Gray model
    Yu-Liang Zhang, Zirong Liu, Zhi Liu, Yi Bai, Hao Chi, Dapeng Chen, Yamin Zhang, Zilin Cui · 2024 · World Journal of Gastrointestinal Oncology
69. Diagnostic and Prognostic Value of Isolated and Combined MCM3 and Glypican-3 Expression in Hepatocellular Carcinoma: A Novel Immunosubtyping Prognostic Model
    Abdelaty Shawky Mohamed, Amal Abd El hafez, Ahmed Eltantawy, Mena Mahfouz · 2022 · Applied immunohistochemistry & molecular morphology
70. The Role of LINC01564, RAMS11, CBX4 and TOP2A in Hepatocellular Carcinoma
    Eman A.E. Badr, Elshaymaa I. Elmongy, Rasha Galal Mostafa, Ibrahim El Tantawy El Sayed, Abdel-Naser Abdel-Aty Gad Allah, Asmaa Khairy Ahmed, Yasser Elghobashy · 2022 · Biomedicines
71. Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma
    Yajing Shen, Jiajun Chen, Jinyu Wu, Tiandong Li, Chuncheng Yi, Keyan Wang, Peng Wang, Changqing Sun, Hua Ye · 2024 · Cancer Prevention Research
72. Serum miRNA-101 expression signature as non-invasive diagnostic biomarker for Hepatitis C virus—associated hepatocellular carcinoma in Egyptian patients
    Mostafa A. Sharafeldin, Reda A. Suef, Adel A. Mousa, Dina Hazem Ziada, Mohamed M. S. Farag · 2025 · Scientific Reports
73. tRF-23-R9J89O9N9:A novel liquid biopsy marker for diagnosis of hepatocellular carcinoma
    Kangfeng Jin, Zhiyun Mao, Yelan Tang, Wei Feng, Shaoqing Ju, Rongrong Jing, Jianhui Chen, Wei Zong · 2025 · Clinica Chimica Acta
74. Real-world treatment patterns and outcomes in patients with early-stage HCC in the US treated with resection or ablation
    Neehar D. Parikh, Ravi A Patel, Jenny Hu, Heide A. Stirnadel-Farrant, Nehemiah Kebede, Cindy Wang, Kirema Garcia-Reyes · 2025 · Hepatic Oncology
75. Dual‐Targeting Peptide Assembly Probe for Precise Detection of Biomarkers of Circulating Tumor Cells in Hepatocellular Carcinoma
    Xing Wang, Jieling Chen, Zehong Chen, Si-Man Luo, Xiaohe Zhang, Yanbin Cai, Lei Zheng, Jie Zhan · 2025 · Small
76. Expression of copper metabolism-related genes is associated with the tumor immune microenvironment and predicts the prognosis of hepatocellular carcinoma
    Lingwang Kong, Miao Liu, Hang Yang, Ping Yan, Yunhai Luo, Song Xiang, Zuotian Huang, Ai Shen · 2024 · Translational Cancer Research
77. Circulatory Agrin Serves as a Prognostic Indicator for Hepatocellular Carcinoma
    Ankita Kapoor, Reza Bayat Mokhtari, Sahithi Sonti, Riya Jayesh Patel, Anthony M. George, Kristopher M. Attwood, Renuka V. Iyer, Sayan Chakraborty · 2024 · Cancers
78. In-silico studies on evaluating the liver-protective effectiveness of a polyherbal formulation in preventing hepatocellular carcinoma progression
    Haritha Kalath, Riya Vishwakarma, Bhavya Banjan, Krishnapriya Ramakrishnan, Abel John Koshy, Rajesh Raju, Niyas Rehman, Amjesh Revikumar · 2024 · In Silico Pharmacology
79. Trends of alkaline phosphatase to prealbumin ratio in patients with hepatitis B linked to hepatocellular carcinoma development
    Wen-Chong Zhen, Jing Sun, Xueting Bai, Qian Zhang, Zi-Han Li, Yixin Zhang, Ruonan Xu, Wu Wei, Zhihan Yao, Chunwen Pu et al. · 2024 · World Journal of Gastroenterology
80. Electrochemical biosensors for hepatocellular carcinoma
    Lei Wang, Jianwei Pan, Bita Badehnoosh · 2025 · Clinica Chimica Acta
81. Identification of the Potential Prognosis Biomarkers in Hepatocellular Carcinoma: An Analysis Based on WGCNA and PPI
    Junting Huang, Yating Zhan, Lili Jiang, Yuxiang Gao, Binyu Zhao, Yuxiao Zhang, Wenjie Zhang, Jianjian Zheng, Jinglu Yu · 2021 · International Journal of General Medicine
82. Transcriptome Analysis of Solute Carrier-Associated Genes in Hepatocellular Carcinoma: Friend or Foe?
    Wei Wei, Rubin Xu, Xiaomei Ying, Liang Chen, Xiaohuan Lu, Qikai Tang, Jiaheng Xie, Hongzhu Yu · 2022 · Frontiers in Genetics
83. Peptide-Conjugated Aggregation-Induced Emission Fluorogenic Probe for Glypican-3 Protein Detection and Hepatocellular Carcinoma Cells Imaging
    Song Zhang, Jiangbo Jing, Lingchen Meng, Bin Xu, Xibo Ma, Wenjing Tian · 2022 · Chemosensors
84. PRR7-AS1 Correlates with Immune Cell Infiltration and Is a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
    Yifan Lu, Songhai Chen, Qingqing Wang, Jie Zhang, Xuanzeng Pei · 2022 · Journal of Oncology
85. Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients
    Qi Huo, Junjie Hu, BINFEN HOU, Mei Zhao, Xue Han, Yulin Du, Yao Li · 2022 · Pathology & Oncology Research
86. miR-29c Suppresses the Malignant Phenotype of Hepatocellular Carcinoma Cells In Vitro by Mediating TPX2 Associated with Immune Infiltration
    Haibo Wang, Wanjin Chen, Yong Fen Qi, Deng Liu, Zhiqiang Liu, Qikun Zhang, Yujiao Yi, Juanru Wang, Wenyong Wu · 2022 · Digestive Diseases and Sciences
87. STX5 Inhibits Hepatocellular Carcinoma Adhesion and Promotes Metastasis by Regulating the PI3K/mTOR Pathway
    Bin Zhang, Ziyin Zhao, Youpeng Wang, Tingting Guo, Mingyang He, Ge Guan, Pai Peng, Jinzhen Cai, Bingyuan Zhang, Xutao Liu et al. · 2023 · Journal of Clinical and Translational Hepatology
88. A nomogram for preoperative prediction of microvascular invasion in ruptured hepatocellular carcinoma
    Feng Xia, Qiao Zhang, Elijah Ndhlovu, Jun Zheng, Hengyi Gao, Guobing Xia · 2023 · European Journal of Gastroenterology & Hepatology
89. Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells
    Jiayao Li, Tian Tian, Bing Han, Ting Yang, Yixin Guo, Jiayu Wu, Yusi Chen, Qin Yang, Rujia Xie · 2023 · World Journal of Gastroenterology
90. Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma
    Qiqi Tao, Zhichao Lang, Yifei Li, Yuxiang Gao, Lifan Lin, Zhengping Yu, Jianjian Zheng, Suhui Yu · 2023 · BMC Cancer
91. Identification of metabolism terms significantly affecting hepatocellular carcinoma immune microenvironment and immunotherapy response
    Xijuan Tan, Sizong Chen, Qiyi Luo, Shenglin You, Hankun Yuan, Jianchu Wang · 2023 · Journal of Cellular and Molecular Medicine
92. Dysfunction of CCT3-associated network signals for the critical state during progression of hepatocellular carcinoma
    Jianwei Wang, Xiaowen Guan, Ning Shang, Di Wu, Zihan Liu, Zhenzhen Guan, Zhizi Zhang, Zhongzhen Jin, Xiaoyi Wei, Xiaoran Liu et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
93. Insights about exosomal circular RNAs as novel biomarkers and therapeutic targets for hepatocellular carcinoma
    Haiyan Zhang, Shanshan Pei, Jiaxuan Li, Jiajie Zhu, Hongyu Li, Guangshang Wu, Ruiqi Weng, Ruyi Chen, Zhongbiao Fang, Jingbo Sun et al. · 2024 · Frontiers in Pharmacology
94. Aristolochic acid I induced mitochondrial Ca2+ accumulation triggers the production of MitoROS and activates Src/FAK pathway in hepatocellular carcinoma cells
    Yongkang Hu, Qi Zhang, Wenjuan Jiang, Xian Wang, Xinlong Guo, Langqun Chen, Siyu Cheng, Jiahui Ying, Jing Ye, Liang Zhang · 2024 · Chemico-Biological Interactions
95. Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma
    Dong Hyun Kim, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee et al. · 2025 · Cancers
96. MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma
    Luca Grisetti, Niệm Văn Thành Võ, Như Nhật Quỳnh Nguyễn, Lory Saveria Crocè, Alessia Visintin, Claudio Tiribelli, Devis Pascut · 2022 · Technology in Cancer Research & Treatment
97. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study
    Chengyu Liu, Zikang Li, Zhilei Zhang, Jinlong Li, Congxi Xu, Yuming Jia, Chong Zhang, Wuhan Yang, Wenchuan Wang, Xiaojuan Wang et al. · 2024 · BMC Gastroenterology
98. Development of an SI-traceable magnetic solid-phase extraction coupled with isotope dilution LC-MS/MS method for accurate quantification of alpha-fetoprotein in human serum
    Haofeng Sun, Jianyi Liu, Qi Zhang, Lei Yang, Dan Song, Min Zhou, Dewei Song · 2025 · Talanta
99. Artificial intelligence-driven CT radiomics model predicts prognosis in TACE-refractory hepatocellular carcinoma
    Hao Li, Yuanyuan Fan, Yipu Li, Weixin Ren · 2025 · Abdominal Radiology
100. CT Hepatic Arteriography for Improved Detection and Ablation of Occult HCC Nodules: A Retrospective Analysis
     Riccardo Muglia, Carlotta Gargiulo, Francesco Saverio Carbone, Ludovico Dulcetta, Martina Bertuletti, Martijn Ruben Meijerink, Robbert S. Puijk, Bruno Calazans Odisio, Paolo Marra, Sandro Sironi · 2025 · CardioVascular and Interventional Radiology